- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05920460
Cognitive Behavioral Therapy for Insomnia and Depression Among Menopausal Women
Cognitive Behavioral Therapy for Insomnia and Depression Among Menopausal Women: A Randomized Control Trial
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mansoura, Egypt
- Mansoura University
-
-
Other
-
Banī Suwayf, Other, Egypt, 62511
- Beni-Suef University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women with depression (BDI-II score of 14-63)
- Women aged between 40 and 55 years old, menopausal (12 consecutive months without menses)
- Women are willing to provide written informed consent to participate in the study.
- Women who have the ability to read and write Arabic language.
- Women who report wake after sleep onset (wakefulness in the middle of the night after falling asleep) of an hour or more on ≥ 3 nights per week and met criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (American Psychiatric Association, 2013) insomnia disorder with onset or exacerbation during the peri- or postmenopausal period per clinical interview with the researcher.
- Women who have a total score of >5 on the Pittsburgh Sleep Quality Index (PSQI), which indicates poor sleep, and a total score of >7 on the Insomnia Severity Index (ISI), which indicates insomnia.
Exclusion Criteria:
- Women who are currently under any type of psychotherapy or have a previous experience of Cognitive Behavioral Therapy.
- Women who have a history of neuropsychiatric illness, cancer, chemotherapy, and sudden stress in the previous 6 months (due to unfortunate events in the family) or have a severe or uncontrolled physical illness.
- Women who are clearly diagnosed as having sleep disorders or obstructive sleep apnea and had taken sleeping medications.
- Women who are on hormonal replacement therapy or cancer therapy or drugs such as tricyclic antidepressants, selective serotonin reuptake inhibitors, sedatives, and other hormones; and those who had undergone hysterectomy with oophorectomy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Group
The Cognitive Behavioral Therapy group received seven weekly face-to-face sleep group Cognitive Behavioral Therapy sessions lasting for 50-60 min.
The Cognitive Behavioral Therapy program was developed by the research team after reviewing the literature and consulting with experts.
Cognitive Behavioral Therapy was held in a lecture hall located in the PPFK branch office before individual counseling was initiated.
|
Brief description of the Cognitive Behavioral Therapy program is given below:
|
|
No Intervention: Control Group
The study participants of the control arm were interviewed separately and were given general health advice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The effect of Cognitive Behavioral Therapy on Womens' insomnia symptom
Time Frame: 8 - 12 weeks
|
the women who received the Cognitive Behavioral Therapy would exhibit a significantly change in insomnia symptom after the program compared to women in the control group. The Insomnia Severity Index (ISI; Morin et al., 2011), the ISI aims to assess the severity of insomnia over the past 2 weeks. |
8 - 12 weeks
|
|
The effect of Cognitive Behavioral Therapy on Womens' depressive levels
Time Frame: 8 - 12 weeks
|
the women who received the Cognitive Behavioral Therapy would exhibit a significantly change in depressive levels after the program compared to women in the control group. The Beck Depression Inventory, 2nd edition (BDI-II; Beck et al., 1996), BDI-II aims to assess the depressive symptoms. It is a 21-item self-report statements about how the person had been feeling in the last week. The BDI-II scores range from 0 to 63, with higher scores indicating greater severity. |
8 - 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation between studied variables before application of the intervention
Time Frame: 8 - 12 weeks
|
Sleep quality index investigates the correlation significantly to insomnia severity index and beck depression inventory. The Pittsburgh Sleep Quality Index (PSQI) 1989, the PSQI is a self-completed questionnaire that assesses sleep quality over the previous month. The scale has 19-items, five of which should be answered by bed mates or roommates. |
8 - 12 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Hashem2023
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on Cognitive Behavioral Therapy Program
-
Virginia Polytechnic Institute and State UniversityNational Institute of Mental Health (NIMH)CompletedAutistic Disorder | Child Development Disorders, PervasiveUnited States
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Institut du Cancer de Montpellier - Val d'AurelleRecruiting
-
New York State Psychiatric InstituteCompletedObsessive-Compulsive DisorderUnited States
-
Cairo UniversityCompletedLow Back Pain, MechanicalEgypt
-
University of OuluOulu University Hospital; Juho Vainio Foundation; Yrjo Jahnsson FoundationCompletedObesity | Diabetes Mellitus, Type 2 | Anhedonia | HypercholesterolemiaFinland
-
Florida International UniversityActive, not recruitingStress | ADHD | Parent-Child Relations | Parenting | Disruptive Behavior DisorderUnited States
-
University Hospital TuebingenCompleted
-
University Hospital, BordeauxCentre National de la Recherche Scientifique, FranceTerminatedObesity | Addiction | Craving | Cognitive Behavioral Therapy | Cognitive Remediation TherapyFrance
-
Linkoeping UniversityOstergotland County Council, SwedenActive, not recruitingCardiac Anxiety | Non-cardiac Chest PainSweden